Trevi Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Trevi Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2018 to 2023.
  • Trevi Therapeutics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $78K, a 13% increase year-over-year.
  • Trevi Therapeutics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $285K, a 44.7% increase year-over-year.
  • Trevi Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $231K, a 77.7% increase from 2022.
  • Trevi Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $130K, a 6.48% decline from 2021.
  • Trevi Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $139K, a 0.73% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $231K +$101K +77.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $130K -$9K -6.48% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $139K +$1K +0.73% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $138K +$13K +10.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $125K +$8K +6.84% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $117K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.